Continuing Conversations
The following information is preliminary and subject to change. All times are listed in Central time.
Continuing Conversations With the Speakers on Challenges in Cell Therapy: Relapse and Toxicities
Chair:
Catherine J. Wu, MD
Dana-Farber Cancer Institute
Boston, MA
Speakers:
Aude G. Chapuis, MD
Fred Hutchinson Cancer Research Center
Seattle, WA
John F. DiPersio, MD, PhD
Washington University School of Medicine
St. Louis, MO
Chiara Bonini, MD
Ospedale San Raffaele
Milano, Italy
Continuing Conversations With the Speakers on Getting the Most from Minimal Residual Disease
Co-Chairs:
Eric D. Hsi, MD
Cleveland Clinic
Cleveland, OH
Lisa G. Roth, MD
Weill Cornell Medicine
New York, NY
Speakers:
Ash A. Alizadeh, MD, PhD
Stanford University
Stanford, CA
Scott R. Manalis, PhD
Massachusetts Institute of Technology
Cambridge, MA
Katie Thoren
Memorial Sloan Kettering Cancer Center
New York, NY
Davide Rossi, MD, PhD
Amedeo Avorgadro Univ. of Eastern Piedmont
Bellinzona, Italy
Continuing Conversations With the Speakers on Gut Microbiome and the Endothelium
Dr. Mark Kahn will discuss the discovery of a gut-brain axis that underlies a brain vascular disease, cerebral cavernous malformation.
Chair:
Wolfram Ruf, MD, PhD
Scripps Research Institute
La Jolla, CA
Speakers:
Weifei Zhu, PhD
Cleveland Clinic Foundation
Cleveland, OH
Martin Kriegel, MD, PhD
Yale School of Medicine
New Haven, CT
Mark L. Kahn, MD
University of Pennsylvania
Philadelphia, PA
Continuing Conversations With the Speakers on RNA in Normal and Malignant Hematopoiesis
Chair:
Kathrin Bernt, MD
Children's Hospital of Philadelphia
Philadelphia, PA
Speakers:
Omar Abdel-Wahab, MD
Memorial Sloan Kettering Cancer Center
New York, NY
Kristin Hope, PhD
McMaster University
Hamilton, ON, Canada
Christopher B. Burge, PhD
Massachusetts Institute of Technology
Cambridge, MA